A new principal component analysis-based approach for testing "similarity" of drug dissolution profiles

European Journal of Pharmaceutical Sciences

Volumn 34, Issue 1, 2008, Pages 66-77

  Maggio, Rubén M ^a   Castellano, Patricia M ^a   Kaufman, Teodoro S ^a,b  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b Universidad Nacional de Rosario   (Argentina)

Author keywords

Acetaminophen; Dissolution profiles; Furosemide; Multivariate method; Principal component analysis; Similarity test

Indexed keywords

FUROSEMIDE; PARACETAMOL;

ALGORITHM; ARTICLE; COMPARATIVE STUDY; DRUG SOLUBILITY; MEASUREMENT; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; SCORING SYSTEM; TABLET;

ACETAMINOPHEN; FUROSEMIDE; PHARMACEUTICAL PREPARATIONS; PRINCIPAL COMPONENT ANALYSIS; SOLUBILITY; TABLETS;

EID: 42649113374     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2008.02.009     Document Type: Article

References (43)

1. Adams E., De Maesschalck R., De Spiegeleer B., Vander Heyden Y., Smeyers-Verbeke J., and Massart D.L. Evaluation of dissolution profiles using principal component analysis. Int. J. Pharm. 212 (2001) 41-53
2. Adams E., Walczak B., Vervaet C., Risha P.G., and Massart D.L. Principal component analysis of dissolution data with missing elements. Int. J. Pharm. 234 (2002) 169-178
3. Chen J.J., and Tsong Y. Multiple-time-point dissolution specifications for a sampling acceptance plan. J. Biopharm. Stat. 7 (1997) 259-270
4. Chow S.-C., and Shao J. On the assessment of similarity for dissolution profiles of two drug products. J. Biopharm. Stat. 12 (2002) 311-321
5. Costa P., and Sousa Lobo J.M. Modelling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13 (2001) 123-133
6. Dressman J.J., and Kramer J. Pharmaceutical dissolution testing (2005), Marcel Dekker, New York
7. Eaton, M.L., Muirhead, R.J., Steeno, G.S., 2003. Biopharmaceutical Report, Winter. Biopharmaceutical Section, American Statistical Association 11, 2-7.
8. Efron B., and Tibshirani R.J. Bootstrap methods for standard errors, confidence intervals and other measures of statistical accuracy. Stat. Sci. 1 (1986) 54-77
9. Efron B., and Tibshirani R.J. An Introduction to the Bootstrap (1993), Chapman & Hall, New York
10. Elkoshi Z. Dissolution specifications based on release rates. J. Pharm. Sci. 88 (1999) 434-444
11. Fassihi R.A., and Ritschel W.A. Multiple layer, direct compression controlled release system: in vitro and in vivo evaluation. J. Pharm. Sci. 82 (1993) 750-754
12. Food and Drug Administration, 1995. FDA Guidance for Industry: Immediate Release Solid Dosage Forms: Scale-up and Post Approval Changes (SUPAC-IR). Chemistry, manufacturing and controls, In vitro dissolution testing and in vivo bioequivalence documentation. Rockville, MD.
13. Goh W.Y., Lim C.P., Peh K.K., and Subari K. Application of a recurrent neural network to prediction of drug dissolution profiles. Neural Comp. Appl. 10 (2002) 311-317
14. Goh W.Y., Lim C.P., and Peh K.K. Predicting drug dissolution profiles with an ensemble of boosted neural networks: a timeseries approach. IEEE Trans. Neural Net. 14 (2003) 459-463
15. Grundy J.S., Anderson K.E., Rogers J.A., and Foster R.T. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. II. Improved in vivo/in vitro correlation using a two-phase dissolution test. J. Control. Release 48 (1997) 9-17
16. Human Medicines Evaluation Unit, 1999. Note For Guidance on quality of modified release products: A. Oral dosage forms; B. Transdermal dosage forms; Section I (Quality), EMEA, CPMP/QWP/604/96.
17. Jackson J.E. A Users Guide to Principal Components (1991), Wiley, New York pp. 45-47
18. Korhonen O., Matero S., Poso A., and Ketolainen J. Partial least square projections to latent structures analysis (PLS) in evaluating and predicting drug release from starch acetate matrix tablets. J. Pharm. Sci. 94 (2005) 2716-2730
19. Leeson L.J. In vitro/in vivo correlations. Drug Inf. J. 29 (1995) 903-915
20. Lim C.P., Quek S.S., and Peh K.K. Application of the Gaussian mixture model to drug dissolution profiles prediction. Neural Comp. Appl. 14 (2005) 345-352
21. Liu J.P., Ma M.-C., and Chow S.-C. Multiple-time-point dissolution specifications for a sampling acceptance plan. Drug Inf. J. 31 (1997) 1255-1271
22. Ma M.-C., Lin R.P., and Liu J.P. Statistical evaluation of dissolution similarity. Stat. Sin. 9 (1999) 1011-1028
23. Ma M.-C., Wang B.B.C., Liu J.-P., and Tsong Y. Assessment of similarity between dissolution profiles. J. Biopharm. Stat. 10 (2000) 229-249
24. Manly B.F.J. Multivariate Statistical Methods: A Primer (1986), Chapman & Hall, New York
25. Mauger J.W., Chilko D., and Howard S. On the analysis of the dissolution data. Drug Dev. Ind. Pharm. 12 (1986) 969-992
26. Moore J.W., and Flanner H.H. Mathematical comparison of curves with an emphasis on in-vitro dissolution profiles. Pharm. Technol. 20 (1996) 64-74
27. Munday D.L., and Fassihi R.A. In vitro-in vivo correlation studies on a novel controlled release theophylline delivery system and on Theo-Dur tablets. Int. J. Pharm. 118 (1995) 251-255
28. Naylor L.J., Bakatselou V., and Dressman J.B. Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Pharm. Res. 10 (1993) 865-870
29. O'Hara T., Dunne A., Butler J., and Devane J. A review of methods used to compare dissolution profile data. Pharm. Sci. Technol. Today 1 (1998) 214-223
30. Peh K.K., Lim C.P., Quek S.S., and Khoh K.H. Use of artificial neural networks to predict drug dissolution profiles and evaluation of network performance using similarity factor. Pharm. Res. 17 (2000) 1384-1388
31. Polli J.E., Rekhi G.S., and Shah V.P. Methods to compare dissolution profiles. Drug Inf. J. 30 (1996) 1113-1120
32. Polli J.E., Rekhi G.S., Augsburger J.J., and Shah V.P. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm. Sci. 86 (1997) 690-700
33. Saranadasa H., and Krishnamoorthy K. A multivariate test for similarity of two dissolution profiles. J. Biopharm. Stat. 15 (2005) 265-278
34. 2. Pharm. Res. 15 (1998) 889-896
35. Tsong Y., and Hammerstrom T. Statistical issues in drug quality control based on dissolution testing. Proceedings of the Biopharmaceutical Section. American Statistical Association (1994) 295-300
36. Tsong Y., Hammerstrom T., Lin K., and On T.E. Dissolution test acceptance sampling plans. J. Biopharm. Stat. 5 (1995) 171-183
37. Tsong Y., Hammerstrom T., Sathe P., and Shah V.P. Statistical assessment of mean difference between two dissolution data sets. Drug Inf. J. 30 (1996) 1105-1112
38. Tsong Y., Hammerstrom T., and Chen J.J. Multipoint dissolution specification and acceptance sampling rule based on profile modeling and principal component analysis. J. Biopharm. Stat. 7 (1997) 423-439
39. USP Convention, 2007. The United States Pharmacopoeia 30. The National Formulary 25, Rockville, MD.
40. Williams R.L., Upton R.A., Ball L., Braun R.L., Lin E.T., Liang-Gee W., and Leeson L.J. Development of new control release formulation of chlorpheniramine maleate using in-vitro, in-vivo correlation. J. Pharm. Sci. 80 (1991) 22-25
41. Wold S., Esbensen K., and Geladi P. Principal component analysis. Chemometrics Intell. Lab. Syst. 2 (1987) 37-52
42. Yu Z., Schwartz J.B., and Sugita E.T. Theophylline controlled-release formulations: in vivo-in vitro correlations. Biopharm. Drug Dispos. 17 (1996) 259-272
43. Yuksel N., Kanik A.E., and Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int. J. Pharm. 209 (2000) 57-67